INSMED INCORPORATED (INSM) Free cash flow 2016–2025
INSMED INCORPORATED (INSM) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$967.6MFY2025 · since FY2016: -$150.9M → -$967.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$967.6M | -37.1% |
| FY2024 | -$705.8M | -28.4% |
| FY2023 | -$549.5M | -33.9% |
| FY2022 | -$410.3M | -10.7% |
| FY2021 | -$370.6M | -64.3% |
| FY2020 | -$225.6M | +23.0% |
| FY2019 | -$292.9M | -8.1% |
| FY2018 | -$271.1M | -66.7% |
| FY2017 | -$162.6M | -7.8% |
| FY2016 | -$150.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice